In the last trading session, 1.27 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.89. With the company’s per share price at $0.79 changed hands at $0.02 or 1.83% during last session, the market valuation stood at $13.41M. PSTV’s last price was a discount, traded about -237.97% off its 52-week high of $2.67. The share price had its 52-week low at $0.24, which suggests the last value was 69.62% up since then. When we look at Plus Therapeutics Inc’s average trading volume, we note the 10-day average is 7.85 million shares, with the 3-month average coming to 16.07 million.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV was in green as seen at the end of in last trading. With action -31.97%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -31.38%, with the 5-day performance at -31.97% in the red. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is -45.20% down. Looking at the short shares, we see there were 0.93 million shares sold at short interest cover period of 0.04 days.
Plus Therapeutics Inc (PSTV) estimates and forecasts
Year-over-year growth is forecast to reach -16.51% down from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 1.11M. 4 analysts are of the opinion that Plus Therapeutics Inc’s revenue for the current quarter will be 1.14M. The company’s revenue for the corresponding quarters a year ago was 1.68M and 1.28M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -33.66%. The estimates for the next quarter sales put growth at -11.06%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.51%. The 2025 estimates are for Plus Therapeutics Inc earnings to increase by 60.68%, but the outlook for the next 5-year period is at 49.80% per year.
PSTV Dividends
Plus Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-26.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.02% of Plus Therapeutics Inc shares while 3.99% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.25%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 34.22 shares estimated at $26999.0 under it, the former controlled 0.20% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.19% of the shares, roughly 32.54 shares worth around $25678.0.
